[144] CoStar Group Inc SEC Filing
CoStar Group Inc (CSGP) Form 144 summary: This Form 144 notifies a proposed sale of 25,000 shares of CoStar common stock through Morgan Stanley Smith Barney, scheduled approximately 08/28/2025, with an aggregate market value listed as $2,258,225.00 and total outstanding shares of 423,650,362.
The filing identifies the seller as Frederick Saint and discloses prior sales by the same person of 25,000 shares on 07/28/2025 for $2,330,827.51 and 25,000 shares on 06/11/2025 for $2,027,382.51. Acquisition details show the shares being sold were originally received as restricted stock on multiple dates in 2021 and 2022.
- Disclosure completeness: Filing lists broker, number of shares, aggregate market value, outstanding shares, and acquisition history.
- Prior sales documented: Shares sold on 06/11/2025 and 07/28/2025 are disclosed with gross proceeds, supporting transparency.
- Insider selling concentration: The filer sold or plans to sell 75,000 shares within a three-month window (25,000 each in June, July, August 2025).
- No 10b5-1 plan details provided: The filing does not state a trading-plan adoption date or provide specific trading-plan terms.
Insights
TL;DR Insider Frederick Saint plans to sell 25,000 CSGP shares; similar sized sales occurred in June and July 2025.
The filing is a routine Form 144 disclosure showing an insider sale through a broker with clear acquisition history (restricted stock grants from 2021–2022). The transaction size (25,000 shares) is small relative to the issuer's outstanding shares (423.65 million), suggesting limited direct dilution or immediate market impact. However, three recent sales of equal size in a three-month span total 75,000 shares, which is relevant for monitoring insider selling patterns.
TL;DR The Form 144 appears complete for Rule 144 disclosure; acquisitions and prior sales are documented.
The notice includes required acquisition details (dates, restricted stock origin, amounts) and prior sales in the past three months, supporting regulatory transparency. The seller certifies no undisclosed material adverse information. The filing does not indicate any trading plan adoption date or other 10b5-1 specifics, so compliance context is limited to the statements provided.